Amprenavir (Compound)

Synonyms:amprenavir, 161814-49-9, Agenerase, Prozei, VX-478, 141W94, KVX-478, Amprenavir (agenerase), VX 478, CHEBI:40050, (3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate, 5S0W860XNR, (3S-(3R*(1R*,2S*)))-(3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl) tetrahydro-3-furanyl carbamate, J05AE05, Vertex VX478, 141 W94, AMV, Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester, Amprenavir [USAN], (3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-1-phenylbutan-2-yl]carbamate, [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate, {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER, DRG-0258, Agenerase (TM), Agenerase (TN), (S)-tetrahydrofuran-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate, [(3S)-tetrahydrofuran-3-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate, GNA & Amprenavir, HHA & Amprenavir, HSDB 7157, DTXSID5046061, UNII-5S0W860XNR, Amprenavir (JAN/USAN/INN), Amprenavir [USAN:INN:BAN], Tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate, 1hpv, 3ekp, 3ekv, 3nuj, 3nuo, VX478, NCGC00159461-02, 1t7j, 3nu3, 3nu4, 3nu5, 3nu6, 3nu9, 3sm2, AMPRENAVIR [MI], AMPRENAVIR [INN], AMPRENAVIR [JAN], AMPRENAVIR [HSDB], AMPRENAVIR [VANDF], APV & AAG, APV & HSA, CHEMBL116, AMPRENAVIR [MART.], AMPRENAVIR [WHO-DD], SCHEMBL34151, (3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate, MLS006011492, AMPRENAVIR [EMA EPAR], BIDD:GT0398, AMPRENAVIR [ORANGE BOOK], 3s43, 3s45, HMS2090N10, BDBM50215393, MFCD00934214, s1639, Amprenavir & alpha1-acid glycoprotein, AKOS000280844, AM84544, BCP9000297, CCG-269742, CS-1410, DB00701, NCGC00159461-07, NCGC00159461-08, 4-Amino-N-((2 syn,3S)-2-hydroxy-4-phenyl-3-((S)-tetrahydrofuran-3-yloxycarbonylamino)-butyl)-N-isobutyl-benzenesulfonamide, Amprenavir 100 microg/mL in Acetonitrile, AS-30915, Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Galanthus nivalis agglutinin (GNA), Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))-, Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester, HY-17430, SMR003885056, BCP0726000051, SW219687-1, C08086, D00894, EN300-123443, AB01275534-01, AB01275534_02, A810295, Q422198, SR-05000001530, SR-05000001530-1, Z1551900491, (3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)-4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate, (3S)-Tetrahydro-3-furyl [(alphaS)-alpha-[(1R-1-hydroxy-2-(N1-isobutylsulfanilamido)ethyl]phenethyl]carbamate, (3S)-tetrahydrofuran-3-yl [(1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-hydroxypropyl]carbamate, [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-oxidanyl-1-phenyl-butan-2-yl]carbamate, Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Hippeastrum hybrid agglutinin( HHA), Carbamic acid,[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-,(3S)-tetrahydro-3-furanyl ester, N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid (3S)-Tetrahydro-3-furanyl Ester, N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamic acid [(3S)-3-oxolanyl] ester
Pubchem:PUBCHEM:65016
Id:a8817c05-42c8-591e-b3c1-0cf5e9d5b043
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Amprenavir's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Amprenavir.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Amprenavir.

Results found

Linked to

 

Label

Description

 

Substance

A Substance

Collection

DrugPage Collection: (DrugCentralID:00200; PubChem_CID:65016, FILE=drugcentral_drug_00200.json)

Collection

Metadatata for amprenavir

Collection

DrugPage Collection: (DrugCentralID:01240; PubChem_CID:65016, FILE=drugcentral_drug_01240.json)

Knowledge Graph Assertion

A Knowledge Graph Assertion from LINCS

Knowledge Graph Assertion

A Knowledge Graph Assertion from LINCS

Knowledge Graph Assertion

A Knowledge Graph Assertion from LINCS

Knowledge Graph Assertion

A Knowledge Graph Assertion from LINCS

Knowledge Graph Assertion

A Knowledge Graph Assertion from LINCS

Knowledge Graph Assertion

A Knowledge Graph Assertion from LINCS


  • Collection

    DrugPage Collection: (DrugCentralID:00200; PubChem_CID:65016, FILE=drugcentral_drug_00200.json)



  • Collection

    DrugPage Collection: (DrugCentralID:01240; PubChem_CID:65016, FILE=drugcentral_drug_01240.json)







  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.